Contract Research Organization (CRO) for Biotech & Pharma

At the Frontier of Innovation

Biotechnology companies have an extraordinary impact on clinical research and have led to scientific breakthroughs varying from genomic to first-in-class immunotherapies. As their contribution to the global biomedical innovation ecosystem grows, CRO partnerships allow them to optimize study flexibility and significantly increase access to advanced expertise and technology.

At SanaClis, we join forces in a collaborative environment to proactively manage end-to-end clinical studies.

25+

years experience in clinical research across all phases & indications

93%

studies finished ahead of schedule and budget

335500+

shipments to sites via our in-house clinical supply chain

3600+

projects as a functional & full-service provider

Oncology: 19.2%

Respiratory: 12.5%

Cardiology: 11.1%

Neurology: 10.4%

Metabolic: 8.4%

Gastroentology: 5.1%

Immunology & Virology: 4.7%

Infections: 4.7%

Gynaecology & Urology: 4.4%

Haematology: 4%

Rheumatology: 3.7%

Dermatology: 3.7%

Psychiatry: 3%

Pain management: 1.7%

Hepatology: 1%

Oto-rhino-laryngology: 1%

Neonatology: 0.7%

Orthopaedics: 0.7%

Endometriosis: Momentum in Early-Phase Research

Endometriosis is one of the most common chronic diseases affecting women of reproductive age. Globally, it is estimated that around 10% of women are diagnosed with endometriosis during their lifetime.

Read the full article here

Rare Disease Clinical Research & Operational Challenges

Progress in rare diseases depends on advancing research, accelerating accurate diagnosis, strengthening regulatory pathways and improving access to effective treatments.

Read the full article here